Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidâ€
Titel:
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acidâ€
Auteur:
Vadhan-Raj, S. von Moos, R. Fallowfield, L.J. Patrick, D.L. Goldwasser, F. Cleeland, C.S. Henry, D.H. Novello, S. Hungria, V. Qian, Y. Feng, A. Yeh, H. Chung, K.